Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 255 of 1,261
  1. US 11369684

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  2. US 11370798

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  3. US 11369566

    Controlled release antimicrobial compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  4. US 11369637

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  5. US 11370764

    RIP1 inhibitory compounds and methods for making and using the same

    Rigel Pharmaceuticals, Inc. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  6. US 11369674

    Treatment method utilizing chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E2 and E1 structural proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  7. US 11369689

    Muscle targeting complexes and uses thereof for treating dystrophinopathies

    Dyne Therapeutics, Inc. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  8. US 11370828

    Anti-coronavirus antibodies and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Svcs. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  9. US 11370769

    TRPC5 inhibitors and methods of using same

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  10. US 11370832

    Anti-Tau antibodies and methods of use thereof

    DENALI THERAPEUTICS INC. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  11. US 11371008

    Systems for producing cellular immunotherapeutics and methods of use thereof

    Northwestern University · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  12. US 11370831

    Compositions and methods for treating and preventing Staphylococcus aureus infections

    XBIOTECH INC. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  13. US 11370827

    Chimeric factor VIII polypeptides and uses thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  14. US 11371062

    RNA-guided nucleic acid modifying enzymes and methods of use thereof

    The Regents of the University of California · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  15. US 11370825

    Polypeptides, cells, and methods involving engineered CD16

    Regents of the University of Minnesota · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  16. US 11370821

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  17. US 11370803

    Heteroaryl plasma kallikrein inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  18. US 11370789

    Octahydro fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  19. US 11370787

    Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulations

    Rigel Pharmaceuticals, Inc. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  20. US 11370786

    GLS1 inhibitors for treating disease

    The Board of Regents of the University of Texas System · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  21. US 11370836

    Monoclonal antibody binding to human IL-5, preparation method therefor and use thereof

    SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  22. US 11370765

    RIP1 inhibitory compounds and methods for making and using the same

    Rigel Pharmaceuticals, Inc. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  23. US 11370774

    Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  24. US 11369896

    Methods for quantitating individual antibodies from a mixture

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.